Literature DB >> 8175923

The processing pathway of prelamin A.

M Sinensky1, K Fantle, M Trujillo, T McLain, A Kupfer, M Dalton.   

Abstract

The conversion of mammalian prelamin A to mature lamin A proceeds through the removal of 18 amino acids from the carboxyl terminus. The initial step in this processing is the isoprenylation of a CAAX box cysteine. This proteolytic event is distinctive for prelamin A among the known prenylated mammalian proteins. Since the carboxyl terminus of prelamin A is removed during maturation, it is not obvious that this protein would undergo the two reactions subsequent to prenylation observed in other CAAX box proteins--the endoproteolytic removal of the carboxyl-terminal 3 amino acids and the subsequent methylation of the now carboxyl-terminal cysteine. To characterize the maturation of prelamin A further, we have developed a CHO-K1 cell line that possesses a dexamethasone-inducible human prelamin A against a genetic background of high mevalonate uptake. Utilizing this cell line in association with antibodies specific to the transgenic prelamin A, we have been able to demonstrate directly in vivo that prelamin A undergoes farnesylation and carboxymethylation prior to conversion to lamin A, as is the case for other prenylated proteins. We have demonstrated previously that in the absence of isoprenylation, conversion of prelamin A to lamin A is blocked, but that unprocessed prelamin A is transported to the nucleus where it can still undergo maturation. Consistent with the implications of these prior studies, we now demonstrate the presence of both subunits of farnesyl-protein transferase in the nucleus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175923     DOI: 10.1242/jcs.107.1.61

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  91 in total

Review 1.  Protein farnesylation and disease.

Authors:  Giuseppe Novelli; Maria Rosaria D'Apice
Journal:  J Inherit Metab Dis       Date:  2012-02-04       Impact factor: 4.982

Review 2.  Understanding the roles of nuclear A- and B-type lamins in brain development.

Authors:  Stephen G Young; Hea-Jin Jung; Catherine Coffinier; Loren G Fong
Journal:  J Biol Chem       Date:  2012-03-13       Impact factor: 5.157

Review 3.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

4.  Mislocalization of prelamin A Tyr646Phe mutant to the nuclear pore complex in human embryonic kidney 293 cells.

Authors:  Yong Pan; Abhimanyu Garg; Anil K Agarwal
Journal:  Biochem Biophys Res Commun       Date:  2007-01-31       Impact factor: 3.575

Review 5.  Mouse models of the laminopathies.

Authors:  Colin L Stewart; Serguei Kozlov; Loren G Fong; Stephen G Young
Journal:  Exp Cell Res       Date:  2007-03-31       Impact factor: 3.905

6.  Regulation of nuclear lamin polymerization by importin alpha.

Authors:  Stephen A Adam; Kaushik Sengupta; Robert D Goldman
Journal:  J Biol Chem       Date:  2008-01-28       Impact factor: 5.157

7.  Analysis of prelamin A biogenesis reveals the nucleus to be a CaaX processing compartment.

Authors:  Jemima Barrowman; Corinne Hamblet; Carolyn M George; Susan Michaelis
Journal:  Mol Biol Cell       Date:  2008-10-15       Impact factor: 4.138

Review 8.  Looking for disease being a model of human aging.

Authors:  I Hausmanowa-Petrusewicz; A Madej-Pilarczyk
Journal:  Acta Myol       Date:  2007-10

9.  Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging.

Authors:  Sofia Rodriguez; Fabio Coppedè; Hanna Sagelius; Maria Eriksson
Journal:  Eur J Hum Genet       Date:  2009-01-28       Impact factor: 4.246

10.  Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism.

Authors:  Jedrzej Małecki; Jørgen Wesche; Camilla Skiple Skjerpen; Antoni Wiedłocha; Sjur Olsnes
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.